Literature DB >> 7594589

Prominent roles of secondary anchor residues in peptide binding to HLA-A24 human class I molecules.

A Kondo1, J Sidney, S Southwood, M F del Guercio, E Appella, H Sakamoto, E Celis, H M Grey, R W Chesnut, R T Kubo, A Sette.   

Abstract

The binding capacity of large sets of peptides corresponding to naturally occurring sequences and carrying previously defined A24-specific motifs was analyzed. It was found that only a minority (9-25%) of the motif-carrying peptides bound the relevant HLA-A molecule with good affinity (IC 50% < or = 50 nM), while the majority of them bound only weakly or not at all (IC 50% > or = 500 nM). By correlating the presence of specific residue types at each position along the peptide sequence with average binding affinity, the prominent influence of specific secondary interactions (secondary anchor residues) was revealed. Moreover, secondary interactions appeared to be size-dependent in that the specific effects detected differed in 9-mer and 10-mer peptide sets. Based on these observations, A24-specific refined motifs were also established for both 9-mer and 10-mer ligands, and their merit was verified by testing the binding capacity of independent sets of synthetic peptides. Such refined motifs should facilitate accurate prediction of potential A24-restricted peptide epitopes. It was also noted that certain crucial secondary interactions appear to be remarkably similar in the case of A24 and other HLA-A molecules previously analyzed (A*0201, A3, A11, and others). This may reflect contributions to binding affinity of relatively invariant residues located within the polymorphic pockets of the HLA binding groove.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7594589

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

1.  Structure-based prediction of binding peptides to MHC class I molecules: application to a broad range of MHC alleles.

Authors:  O Schueler-Furman; Y Altuvia; A Sette; H Margalit
Journal:  Protein Sci       Date:  2000-09       Impact factor: 6.725

2.  Class I molecules with similar peptide-binding specificities are the result of both common ancestry and convergent evolution.

Authors:  Alessandro Sette; John Sidney; Brian D Livingston; John L Dzuris; Claire Crimi; Christopher M Walker; Scott Southwood; Edward J Collins; Austin L Hughes
Journal:  Immunogenetics       Date:  2003-02-14       Impact factor: 2.846

3.  Automated generation and evaluation of specific MHC binding predictive tools: ARB matrix applications.

Authors:  Huynh-Hoa Bui; John Sidney; Bjoern Peters; Muthuraman Sathiamurthy; Asabe Sinichi; Kelly-Anne Purton; Bianca R Mothé; Francis V Chisari; David I Watkins; Alessandro Sette
Journal:  Immunogenetics       Date:  2005-05-03       Impact factor: 2.846

4.  Classification of A1- and A24-supertype molecules by analysis of their MHC-peptide binding repertoires.

Authors:  John Sidney; Scott Southwood; Alessandro Sette
Journal:  Immunogenetics       Date:  2005-07-08       Impact factor: 2.846

5.  Detailed characterization of the peptide binding specificity of five common Patr class I MHC molecules.

Authors:  John Sidney; Shinichi Asabe; Bjoern Peters; Kelly-Anne Purton; Josan Chung; Timothy J Pencille; Robert Purcell; Christopher M Walker; Francis V Chisari; Alessandro Sette
Journal:  Immunogenetics       Date:  2006-06-22       Impact factor: 2.846

6.  Role of strong anchor residues in the effective binding of 10-mer and 11-mer peptides to HLA-A*2402 molecules.

Authors:  M Ibe; Y I Moore; K Miwa; Y Kaneko; S Yokota; M Takiguchi
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

7.  Measurement of MHC/peptide interactions by gel filtration or monoclonal antibody capture.

Authors:  John Sidney; Scott Southwood; Carrie Moore; Carla Oseroff; Clemencia Pinilla; Howard M Grey; Alessandro Sette
Journal:  Curr Protoc Immunol       Date:  2013-02

8.  Interferon-gamma is produced by CD8 T cells in response to HLA-A24-restricted hepatitis C virus epitopes after sustained virus loss.

Authors:  K Kobayashi; M Ishii; M Shiina; Y Ueno; Y Kondo; A Kanno; Y Miyazaki; T Yamamoto; T Kobayashi; H Niitsuma; Y Kikumoto; H Takizawa; T Shimosegawa
Journal:  Clin Exp Immunol       Date:  2005-07       Impact factor: 4.330

9.  Characterization of the peptide-binding specificity of Mamu-A*11 results in the identification of SIV-derived epitopes and interspecies cross-reactivity.

Authors:  Alessandro Sette; John Sidney; Huynh-Hoa Bui; Marie-France del Guercio; Jeff Alexander; John Loffredo; David I Watkins; Bianca R Mothé
Journal:  Immunogenetics       Date:  2005-03-04       Impact factor: 2.846

10.  Aberrant expression and potency as a cancer immunotherapy target of alpha-methylacyl-coenzyme A racemase in prostate cancer.

Authors:  Ichiya Honma; Toshihiko Torigoe; Yoshihiko Hirohashi; Hiroshi Kitamura; Eiji Sato; Naoya Masumori; Yasuaki Tamura; Taiji Tsukamoto; Noriyuki Sato
Journal:  J Transl Med       Date:  2009-12-09       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.